Cargando…
Trends of risk classification and primary therapy for Japanese patients with prostate cancer in Nara Uro-Oncological Research Group (NUORG)–a comparison between 2004-2006 and 2007-2009
BACKGROUND: To assess the trends of risk classification and primary therapy in Japanese patients who were diagnosed with prostate cancer between 2004-2006 and 2007-2009. METHODS: A total of 4752 patients who were newly diagnosed with prostate cancer at Nara Medical University and its 23 affiliated h...
Autores principales: | Tanaka, Nobumichi, Hirayama, Akihide, Yoneda, Tatsuo, Yoshida, Katsunori, Shimada, Keiji, Konishi, Noboru, Fujimoto, Kiyohide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028809/ https://www.ncbi.nlm.nih.gov/pubmed/24325407 http://dx.doi.org/10.1186/1471-2407-13-588 |
Ejemplares similares
-
Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012
por: Tanaka, Nobumichi, et al.
Publicado: (2017) -
The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram
por: Tanaka, Nobumichi, et al.
Publicado: (2015) -
The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-oncological research group registration
por: Tanaka, Nobumichi, et al.
Publicado: (2011) -
Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy
por: Tanaka, Nobumichi, et al.
Publicado: (2012) -
Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
por: Tanaka, Nobumichi, et al.
Publicado: (2013)